BenQ Mobile GmbH & Co. OHG A31A Manuel D’Utilisation

©

 BenQ Mobile GmbH

 & Co. OH

G 200

4, Z

:\A

31_

FINCH_1

\outp

ut\

FUG\

A31a

_Fi

nch

_FCC_

us-

 of A31a FCC us-en,  (16.02.2006, 13:32)

Temp

late:

 X75,

 Ver
sion 2

.1

; VAR 

Language: am;

 VAR issu

e date:

 05071

1

they were more likely to be on the side 

of the head where the mobile phone 

was used. Because this occurred in only 

a small number of cases, the increased 

likelihood was too small to be statisti-

cally significant.

4

In summary, we do not have enough in-

formation at this point to assure the pub-

lic that there are, or are not, any low inci-

dent health problems associated with use 

of mobile phones. FDA continues to work 

with all parties, including other federal 

agencies and industry, to assure that re-

search is undertaken to provide the nec-

essary answers to the outstanding ques-

tions about the safety of mobile phones.
What is known about cases of human cancer 

Some people who have used mobile 

phones have been diagnosed with brain 

cancer. But it is important to understand 

that this type of cancer also occurs 

among people who have not used mobile 

phones. In fact, brain cancer occurs in the 

U.S. population at a rate of about 6 new 

cases per 100,000 people each year. At 

that rate, assuming 80 million users of 

mobile phones (a number increasing at a 

rate of about 1 million per month), about 

4800 cases of brain cancer would be ex-

pected each year among those 80 million 

people, whether or not they used their 

phones. Thus it is not possible to tell 

whether any individual's cancer arose be-

cause of the phone, or whether it would 

have happened anyway. A key question is 

whether the risk of getting a particular 

form of cancer is greater among people 

who use mobile phones than among the 

rest of the population. One way to an-

swer that question is to compare the us-

age of mobile phones among people with 

brain cancer with the use of mobile 

phones among appropriately matched 

people without brain cancer. This is called 

a case-control study. The current case-

control study of brain cancers by the Na-

tional Cancer Institute, as well as the fol-

low-up research to be sponsored by in-

dustry, will begin to generate this type of 

information.
What is FDA's role concerning the safety of 

Under the law, FDA does not review the 

safety of radiation emitting consumer 

products such as mobile phones before 

marketing, as it does with new drugs or 

medical devices. However, the agency 

has authority to take action if mobile 

phones are shown to emit radiation at a 

level that is hazardous to the user. In such 

a case, FDA could require the manufactur-

ers of mobile phones to notify users of 

the health hazard and to repair, replace or 

recall the phones so that the hazard no 

longer exists. 

Although the existing scientific data do 

not justify FDA regulatory actions at this 

time, FDA has urged the mobile phone in-

dustry to take a number of steps to assure 

public safety. The agency has recom-

mended that the industry:
• Support needed research into possible 

biological effects of RF of the type emit-

ted by mobile phones;

• Design mobile phones in a way that 

minimizes any RF exposure to the user 

that is not necessary for device func-

tion; and

• Cooperate in providing mobile phone 

users with the best possible informa-

tion on what is known about possible 

effects of mobile phone use on human 

health.

• At the same time, FDA belongs to an in-

teragency working group of the federal 

agencies that have responsibility for 

different aspects of mobile phone safe-

ty to ensure a coordinated effort at the 

federal level. These agencies are:

• National Institute for Occupational 

Safety and Health

• Environmental Protection Agency
• Federal Communications Commission